Cardio Diagnostics Holdings, Inc. has filed a notice of a Private Investment in Public Equity (PIPE) offering of securities to raise $1,000,000.00 in New Funding.
According to filings with the U.S. Securities and Exchange Commission, Cardio Diagnostics Holdings, Inc. is raising $1,000,000.00 in new funding. About Cardio Diagnostics Holdings, Inc.: Cardio Diagnostics Holdings, Inc., an artificial intelligence-powered precision cardiovascular medicine company, develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment test targeting CHD events, including heart attacks; and PrecisionCHD, an integrated epigenetic-genetic blood test for the early detection of coronary heart disease. The company was founded in 2017 and is headquartered in Chicago, Illinois.
To learn more about Cardio Diagnostics Holdings, Inc., visit http://cardiodiagnosticsinc.com/
Contact:
Meeshanthini Dogan, Chief Executive Officer
302-281-2147
SOURCE: http://www.intelligence360.io
Copyright (c) 2024 SI360 Inc. All rights reserved.